Cosmo Artificial Intelligence – AI

Dublin, Ireland  All Ireland companies → — Founded 1997
Clinical AI Platform Healthcare Conglomerate Medical Device / Hardware
Colorectal Surgery Gastroenterology Oncology
Gastroenterology AI
Public (Cosmo Pharmaceuticals N.V. is listed on SIX Swiss Exchange)

Products

GI Genius Module
Cosmo Artificial Intelligence - Ai, Ltd.
Gastroenterology AI
The GI Genius™ intelligent endoscopy module is an AI-powered system designed to assist physicians in the real-time detection of colorectal polyps during colonoscopy, acting as a "second set of eyes" to enhance visualization and improve detection rates.
GI Genius™ Module 300
Cosmo Artificial Intelligence - AI
Gastroenterology AI
The GI Genius™ Module 300 is an FDA-cleared, AI-powered computer-aided detection system that assists physicians in real-time polyp and lesion detection during colonoscopies, enhancing adenoma detection rates and improving early diagnosis of colorectal cancer.
ColonPRO™ 4.0 (CPRO40S-US)
Medtronic
Gastroenterology AI
ColonPRO™ 4.0 is an FDA-cleared, AI-powered computer-assisted detection system that integrates with standard colonoscopy equipment to help endoscopists identify colonic polyps and adenomas in real-time, improving detection rates during screening and surveillance procedures.

See all 5 products →

About Cosmo Artificial Intelligence – AI

Cosmo Artificial Intelligence (Cosmo AI) is a life sciences company specializing in MedTech AI, dermatology, and gastroenterology. The company focuses on developing and manufacturing innovative, high-quality products and technologies, particularly those supported by AI and digital health, to enhance healthcare delivery. Cosmo AI’s mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology, with a vision to build health confidence globally.

For physicians, Cosmo AI engineers technologies that support high-quality care by complementing clinical expertise through thoughtful innovation. Their work in AI and intelligent systems aims to improve detection, simplify workflows, and support more personalized care experiences. A flagship product is the GI Genius™ intelligent endoscopy module, an AI-powered system designed to assist endoscopists in real-time detection of colonic mucosal lesions, such as polyps and adenomas, during colonoscopies. This system has demonstrated improved diagnostic performance compared to standard colonoscopy, with clinical evidence showing a significant increase in adenoma detection rate. Cosmo AI also offers ColonPRO™, an application to reduce the miss rate in colorectal cancer screening colonoscopy through polyp detection (CADe), with advanced features like polyp characterization (CADx), sizing (CADs), and Computer Aided Quality (CAQ) reporting.

Cosmo AI is actively expanding the clinical scope of its GI Genius™ platform beyond colorectal cancer screening into upper gastrointestinal indications, including a strategic R&D collaboration to advance AI-based detection of early neoplasia in Barrett’s esophagus. The company emphasizes building medical-grade AI systems that operate in real clinical environments and support physicians during procedures, leveraging advanced computing technologies for real-time AI inference.

Focus Areas

MedTech AI gastroenterology endoscopy colorectal cancer screening polyp detection AI-assisted diagnosis drug development dermatology digital health

Business Intelligence

TechnologyCloud-native, deep learning algorithms, real-time AI system, AI Access platform (for hosting third-party AI applications)

What Physicians Need to Know

Gastrointestinal Disorders & Endoscopy
Cosmo AI specializes in real-time AI assistance during GI endoscopy procedures, particularly for colorectal cancer screening and polyp detection. Their flagship product, GI Genius™, is an FDA-cleared real-time AI platform that has supported over 4 million patients worldwide. It significantly improves diagnostic performance by using deep learning algorithms to alert physicians to the presence of lesions and can reduce missed polyp rates by up to 50%. The GI Genius™ platform is expanding its clinical scope beyond colorectal applications to include the detection of early neoplasia in Barrett's esophagus.
Colorectal Cancer Screening & Polyp Detection
Cosmo AI's ColonPRO™ application, part of the GI Genius™ platform, is designed to reduce the miss rate in colorectal cancer screening colonoscopy. It includes advanced features such as polyp characterization (CADx), sizing (CADs), and Computer Aided Quality (CAQ) reporting. The GI Genius™ module was the first real-time AI system in healthcare to introduce real-time colorectal polyp detection in 2019 and received the FDA's first De Novo clearance for an AI GI device in 2021.
Real-time AI Assistance During Medical Procedures
A key specialization is providing real-time AI assistance during medical procedures, complementing physicians' clinical expertise to improve detection, simplify workflows, and support personalized care. Cosmo's AI systems are engineered to operate in real-time during medical procedures, assisting with detection, decision support, and workflow optimization.
MedTech AI
Cosmo is a life sciences company innovating at the intersection of science and technology in MedTech AI, dermatology, gastroenterology, and contract manufacturing. They are focused on building medical-grade AI systems that operate in real clinical environments.
Dermatology
Cosmo is involved in dermatology, with products like Winlevi® for acne treatment and a topical solution for androgenetic alopecia in its pipeline. AI in dermatology can assist in diagnosing skin disorders, analyzing patient notes, and providing personalized treatment recommendations.
Specialty Pharmaceuticals & CDMO
Cosmo is a specialty pharmaceutical company focused on developing and commercializing products for gastrointestinal disorders and improving endoscopy quality. They also offer contract development and manufacturing (CDMO) services, leveraging proprietary formulation platforms and cGMP-compliant facilities.
Physician Tip

Cosmo AI's GI Genius™ platform offers real-time AI insights during endoscopy, which can significantly enhance polyp detection rates and improve diagnostic accuracy, ultimately aiding in earlier detection of colorectal cancer. The system is designed for seamless integration with existing endoscopy equipment, minimizing disruption to current workflows. Physicians can expect improved detection, simplified workflows, and support for more personalized care experiences. Furthermore, Cosmo is expanding its AI applications to other GI indications like Barrett's esophagus, indicating future advancements in upper GI endoscopy. For dermatology, AI tools can offer objective, data-driven recommendations for diagnosis and treatment planning, complementing clinical expertise.

The GI Genius™ intelligent endoscopy module is designed for seamless integration with all major endoscopic processors and existing endoscopy towers, high-definition endoscopes, video processors, and display monitors. Cosmo's engineering teams leverage advanced accelerated computing technologies from NVIDIA, and the GI Genius™ Module 300 is built on NVIDIA IGX, serving as an open compute engine for Cosmo and partner-developed AI applications. They also have an 'Innovation Center' and 'GI Genius™ AI Access developer kit' to allow developers and startups to build, test, and refine real-time AI solutions for medical procedures, accelerating time-to-market. Medtronic is the sole distributor, marketer, and owner of GI Genius trademarks.

Products by Cosmo Artificial Intelligence – AI

5 products in the directory

GI Genius Module
Cosmo Artificial Intelligence - Ai, Ltd.
Gastroenterology AI
The GI Genius™ intelligent endoscopy module is an AI-powered system designed to assist physicians in the real-time detection of colorectal polyps during colonoscopy, acting as a "second set of eyes" to enhance visualization and improve detection rates.
GI Genius™ Module 300
Cosmo Artificial Intelligence - AI
Gastroenterology AI
The GI Genius™ Module 300 is an FDA-cleared, AI-powered computer-aided detection system that assists physicians in real-time polyp and lesion detection during colonoscopies, enhancing adenoma detection rates and improving early diagnosis of colorectal cancer.
ColonPRO™ 4.0 (CPRO40S-US)
Medtronic
Gastroenterology AI
ColonPRO™ 4.0 is an FDA-cleared, AI-powered computer-assisted detection system that integrates with standard colonoscopy equipment to help endoscopists identify colonic polyps and adenomas in real-time, improving detection rates during screening and surveillance procedures.
GI Genius
Cosmo Artificial Intelligence - AI
Gastroenterology AI
GI Genius is the first FDA-cleared AI-powered endoscopy module that assists physicians in real-time polyp detection during colonoscopies to improve colorectal cancer screening and surveillance.
GI Genius™ Module 100
Cosmo Artificial Intelligence - AI
Gastroenterology AI
The GI Genius™ Module 100 is an FDA-cleared, AI-powered computer-aided detection system that assists physicians in real-time detection of colonic polyps and adenomas during colonoscopy, enhancing visualization and improving detection rates.

What the Web Says

Cosmo Artificial Intelligence (Cosmo AI) appears to be a platform offering various AI tools, primarily focused on video creation from text, AI chatbots, and content generation. Users generally praise its ease of use, quick video production, and responsive customer support. However, some users have noted limitations in customization and occasional buggy features. There also seems to be some confusion or multiple entities operating under similar "Cosmo AI" or "Cosmos AI" names, with different functionalities and reviews.

Overall: Mixed

Strengths

  • Ease of use for converting text to professional videos.
  • Fast video production.
  • Responsive and helpful customer support.
  • Easy setup and seamless integration with platforms.
  • Affordable pricing.
  • Ability to generate unique, plagiarism-free content and AI images.

Limitations

  • Limited customization options for visuals and video flows.
  • Buggy features leading to mismatched visuals and tone.
  • Limited functionality requiring manual adjustments.
  • Missing features for specific visuals and branding.
  • Limited features on the mobile version.
  • Visuals in generated videos may not always align well with the provided text.

Based on reviews from: G2, Capterra, Reddit, Medium, Insidr.ai, Google Play

Last updated: 2026-10-19

Videos

News, demos, and interviews about Cosmo Artificial Intelligence – AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Cosmo Artificial Intelligence – AI →

View all on YouTube

Press & Coverage

PR Newswire
Cosmo announces FDA approval of GI Genius™ intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy
Cosmo Pharmaceuticals announced FDA approval for its GI Genius™ intelligent endoscopy system, the first AI device for lesion detection during colonoscopy, marking a significant milestone after over a decade of research.
2021-04
Medtronic Newsroom
Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care
Medtronic announced an expanded partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals, to further integrate AI into endoscopic modules, building on the success of the GI Genius™ intelligent endoscopy module.
2023-12
Fierce Biotech
Medtronic doubles down on endoscopy AI partnership, inking $200M deal with Cosmo Pharmaceuticals
Medtronic expanded its AI partnership with Cosmo Pharmaceuticals, committing up to $200 million to build a platform for multiple AI-powered diagnostics for endoscopic exams, leveraging Cosmo's GI Genius system.
2023-12
Medical Device Network
Medtronic partners with Cosmo to use AI to improve endoscopic software
Medtronic expanded its partnership with Cosmo Pharmaceuticals' subsidiary, Cosmo Intelligent Medical Devices, to integrate AI into endoscopic modules, building on the success of the GI Genius intelligent endoscopy module.
2024-01
Nasdaq
Cosmo Intelligent Medical Devices Unveils Next Generation GI Genius(TM) Hardware with New FDA Clearance
Cosmo Intelligent Medical Devices announced FDA 510(k) clearance for the next generation GI Genius™ hardware, featuring enhanced AI capabilities and the ColonPRO™ software for polyp detection during colorectal cancer screenings.
2024-07
Medical Design & Outsourcing
AI tips for device developers from Medtronic partner Cosmo Intelligent Medical Devices
Cosmo Intelligent Medical Devices President Nhan Ngo Dinh and SVP Andrea Cherubini shared insights on developing AI for medical devices, highlighting their work on the Medtronic GI Genius system for polyp detection.
2024-08
Newsfile Corp.
Cosmo Appoints Andrea Cherubini as Chief AI Officer to Drive AI Expansion Across Portfolio
Cosmo Pharmaceuticals appointed Andrea Cherubini as Chief AI Officer to lead the integration of AI across its entire portfolio, including gastroenterology and dermatology pipelines, and drug discovery.
2025-02
FirstWord HealthTech
Cosmo Announces Strategic R&D Collaboration to Advance AI-Based Detection of Early Neoplasia in Barrett's Esophagus
Cosmo Pharmaceuticals announced a strategic R&D agreement with Amsterdam UMC and Eindhoven University of Technology to develop an AI-based system for detecting early neoplasia in Barrett's esophagus, expanding the GI Genius™ platform's scope.
2026-03

Frequently Asked Questions

Cosmo Artificial Intelligence offers the GI Genius™ intelligent endoscopy module, which is an FDA-cleared, AI-powered system designed for real-time detection of colorectal polyps during colonoscopies. This platform, including the ColonPRO™ application, acts as a 'second set of eyes' to enhance visualization and improve adenoma detection rates, aiding in early diagnosis of colorectal cancer.
Cosmo Artificial Intelligence develops real-time AI systems that operate during medical procedures to assist physicians with detection, decision support, and workflow optimization. For example, the GI Genius™ module integrates seamlessly with existing endoscopy equipment and uses deep learning algorithms to alert physicians to the presence of lesions with visual markers, improving diagnostic performance.
Cosmo is a life sciences company with a broad focus that includes MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). While GI Genius™ is a key AI product, Cosmo also develops and manufactures specialty pharmaceuticals and aims to expand its AI applications across its entire product portfolio, including drug development.
Cosmo Artificial Intelligence prioritizes security and data protection in its AI strategy, aligning with regulations like GDPR and the EU AI Act, especially for high-risk AI in medicine. They emphasize robust data preprocessing, patient data privacy, security measures like encryption, and clear rationale for AI predictions to support clinical decision-making and trust.
Cosmo Artificial Intelligence has a significant partnership with Medtronic for the global distribution of its GI Genius™ intelligent endoscopy module. They also collaborate with NVIDIA, leveraging their accelerated computing technologies for real-time AI systems. These partnerships, along with a strong financial position and a vision for substantial recurring revenues by 2030, indicate a stable company with a focus on innovation and growth.
Yes, Cosmo is actively expanding the clinical scope of its GI Genius™ platform beyond colorectal cancer screening. They have a strategic R&D agreement with Amsterdam UMC and Eindhoven University of Technology to develop and clinically validate an AI-based system for detecting early neoplasia in Barrett's Esophagus, with the goal of supporting future regulatory submissions in Europe and the United States.

Related Companies

CapsoVision is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence (AI) technologies for capsule endoscopy solutions. Their primary goal is to identify abnormalities of the gastrointestinal (GI) tract for diagnostic and screening purposes. [7] Their flagship product, the CapsoCam Plus system, is a single-use capsule endoscope equipped with four cameras, providing […]

Exact Sciences is a molecular diagnostics company dedicated to the early detection and prevention of cancer, as well as guiding treatment decisions. The company is best known for its non-invasive colorectal cancer screening test, Cologuard, which analyzes stool samples for DNA markers and occult hemoglobin to assess a patient’s risk of colorectal cancer. Cologuard was […]

Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]

Motus GI Holdings, Inc. is a medical technology company that develops innovative solutions for gastrointestinal procedures, primarily focusing on enhancing colonoscopy outcomes. Their flagship product, the Pure-Vu System, is a U.S. FDA-cleared and CE-marked medical device designed to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper GI endoscopy procedures. The […]

Ambu is a global MedTech company that has been innovating healthcare solutions for over 85 years, with a strong focus on single-use medical devices. The company’s mission is to improve patient care through practical innovation, patient safety, and workflow efficiency. Ambu is particularly recognized for its pioneering work in single-use endoscopy, offering a comprehensive portfolio […]

Odin Medical Ltd. (operating as Odin Vision, an Olympus Corporation company) is a pioneering cloud AI endoscopy company focused on revolutionizing endoscopy with next-generation AI-enabled applications. [2, 7] The company develops AI-powered medical imaging software that utilizes machine learning algorithms to analyze medical images and support endoscopists’ decision-making during procedures. [24] Their technology aims to […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.